Paediatric osteoarticular tuberculosis: A review.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

Conflict of interest statement: We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. 19. BMJ Case Rep. 2022 Jul 7;15(7):e249063. doi: 10.1136/bcr-2022-249063. Case of reactive sacroiliitis possibly induced by an mRNA coronavirus disease vaccine. Roux N(1), Poussing S(2), Maurier F(3). Author information: (1)Rheumatology Department, UNEOS Hôpitaux Privés de Metz, Metz-Vantoux, Lorraine, France. (2)Biological Laboratory, UNEOS Hopitaux Prives de Metz, Metz, Lorraine, France. (3)Internal Medicine and Clinical Immunology Department, UNEOS Hopitaux Prives de Metz, Metz-Vantoux, Lorraine, France francois.maurier@uneos.fr. A woman in her 30s received a second dose, first booster, Corminaty vaccine against the SARS-CoV-2. Three days later, the patient developed unilateral sacroiliitis. A pelvic scan revealed inflammatory joint edges, bone erosion and a heterogeneous mass of 2.5 cm in the psoas muscle. Joint puncture revealed no microcrystalline deposits, but bone marrow cells, erythroblast were identified. The standard bacterial cultures and culture for mycobacteria were negative. HLA B27 was negative, and no seroconversion was identified for HIV, Epstein-Barr virus, cytomegalovirus, chlamydia or Quantiferon. Two months later, the sacroiliitis resolved.The aetiologic approach of this erosive unilateral acute sacroiliitis in a person naïve to rheumatologic pathology was negative for inflammatory or infectious sacroiliitis. Arthralgias after vaccination are expected. Arthritis is less common, and acute sacroiliitis has not yet been described. Acute sacroiliitis may be considered a reactive sacroiliitis to the anti-COVID-19 mRNA vaccine. © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ. DOI: 10.1136/bcr-2022-249063 PMCID: PMC9263939